INTRODUCTION
Hepatocellular carcinoma (HCC) is a well known complication of genetic haemochromatosis (GH), the estimated relative risk being approximately 220. It is widely stated that HCC develops only in patients with cirrhosis in GH 2, 3 and most recently "there is no published report of the occurence of liver cancer in a noncirrhotic patient with haemochromatosis''4. There are two case reports of HCC after reversal of cirrhosis with venesection5,6, and one report ofHCC developing in two patients with fibrosis but no cirrhosis7. We present details of a patient with GH in whom an HCC developed in a liver with normal architecture.
CASE REPORT
The patient was 72 year old man when he was referred to the Royal Free Hospital. Haemochromatosis , iron saturation 47% (20-40) and ferritin was raised at 442 ug/1 (39-340). CT scan of the abdomen revealed a well demarcated lesion in the right lobe of the liver which, with the markedly raised AFP, was considered diagnostic ofan HCC. Serological markers for hepatitis B and C viruses were negative. Bone scan and chest CT scan revealed no evidence ofmetastatic disease. A biopsy ofthe left lobe ofthe liver revealed no evidence ofcirrhosis but a considerable amount ofiron within hepatocytes. Previous liver biopsies were reviewed at this hospital.
The patient was treated initially by targeted chemotherapy with lipiodol and epirubicin administered angiographically via the hepatic artery; he subsequently underwent a right partial hepatectomy. Histology of the resected specimen revealed a moderately differentiated HCC arising in a liver with normal architecture (Figs. and  2 ). There was no significant portal inflammation and no fibrosis; however, there was patchy but extensive grade 3 siderosis (Fig 3) . The resection margins were free of 
COMMENT
This case demonstrates that hepatocellular carcinoma may arise in the liver ofa patient with GH in the absence of cirrhosis; as the patient had a surgical resection the question of sampling error does not arise. Tumour surveillance, therefore, is advisable in patients with GH without cirrhosis as tumours may arise, though very rarely. There were no other identifiable aetiological factors which could explain the HCC.
The pathophysiology ofiron overload is incompletely understood. Iron is thought to cause toxicity through its ability to form highly reactive free radicals which cause lipid peroxidation affecting particularly mitochondrial and microsomal membrane lipids8. Ensuing lysosomal instability is thought to be fundamental in producing hepatocyte toxicity. Chronic liver cell damage itself, regardless of aetiology, produces a proliferative response which as a result of increased cell growth fosters secondary genetic events. These may be activation of protoonco-genes or inactivation of suppressor genes, thus programming the cell for unrestrained growth9. Iron itself, again possibly by peroxidation, has been shown to be directly mutagenic . 
